You are here

  • Home
  • Archive
  • Volume 11, Issue 6
  • Study protocol for SKIPMDD: subcutaneous ketamine infusion in palliative care patients with advanced life limiting illnesses for major depressive disorder (phase II pilot feasibility study)

Citation Tools

Article menu

Download PDFPDF

XML
Palliative care
Protocol
Study protocol for SKIPMDD: subcutaneous ketamine infusion in palliative care patients with advanced life limiting illnesses for major depressive disorder (phase II pilot feasibility study)

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Lee W, Sheehan C, Chye R, et al
Study protocol for SKIPMDD: subcutaneous ketamine infusion in palliative care patients with advanced life limiting illnesses for major depressive disorder (phase II pilot feasibility study)
BMJ Open 2021;11:e052312. doi: 10.1136/bmjopen-2021-052312